Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Towards a quality assurance system for medication reviews in German community pharmacies

  • At: PPR 2022 (2022)
  • Type: Poster
  • By: KEIP, Carolin (Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn)
  • Co-author(s): Carolin Keip, PhD Student, Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, Germany
    Sophie Scheppe, Institute of Pharmaceutical and Medicinal Chemistry, Clinical Pharmacy, Westfaelische Wilhelms-University Muenster, Germany
    Isabel Waltering
    Verena Kurth
    Ronja Woltersdorf
    Ulrich Jaehde
    Georg Hempel
  • Abstract:

    Background information: Medication reviews in community pharmacies are a common method to improve medication safety. In Germany, several training programmes exist as well as guidelines for conducting medication reviews by the federal chamber of pharmacists [1,2]. Particularly with regard to quality assurance suitable instruments are needed to measure and guarantee high quality. For this purpose, quality indicators are often used within the healthcare sector but for pharmaceutical services suitable indicators are still lacking in Germany.
    Purpose: The project aims at defining a set of quality indicators complemented by a proficiency test system to assess medication reviews type 2a performed in German community pharmacies.
    Method: A systematic literature search was carried out in PubMed and Google Scholar to identify existing quality indicators for pharmaceutical care used in other countries. In addition, further indicators identified in existing guidelines were added. After discussion by an expert panel a preliminary indicator set was defined. Within a two-step Delphi survey, participants were asked to evaluate the proposed quality indicators regarding their suitability to measure the quality of medication reviews type 2a in community pharmacies using the RUMBA criteria (Relevant, Understandable, Measurable, Behaviourable, Achievable). An additional Delphi survey was prepared to refine the indicator set in order to address current progress regarding the implementation and remuneration of pharmaceutical services in Germany.
    Results: 350 indicators were identified by systematic literature search, from which 23 where applicable to the community pharmacy setting in Germany. In addition, three indicators were taken out of guidelines on medication reviews and six other indicators were suggested by the experts. Among these candidate indicators, the expert panel defined a preliminary set of 12 indicators, which was then further evaluated in the first Delphi survey. An indicator set of six quality indicators was obtained, including three structure, one process and two outcome indicators. During the refinement process one additional structure and one process indicator were added for evaluation in the second Delphi survey.
    Conclusion: After refinement, a set of indicators will be available to assess the quality of medication reviews type 2a in the German community pharmacy setting. In the next step practicability, reliability and validity of these indicators will be evaluated while implementing a suitable proficiency test system.

    References:
    [1] German Federal Chamber of Pharmacists [Bundesapothekerkammer]. Medication review. Quality assurance guideline. Version as of 29 November 2017. www.abda.de. [accessed 13 April 2022]
    [2] Federal Association of German Pharmacists e.V. [ABDA]. Medication review and medication management. Position paper. Version as of 24 Jun 2014. www.abda.de. [accessed 13 April 2022]

Last update 4 October 2019

FIP Congresses